Pinnacle Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.2M | Sell |
|
|||||
|
2025
Q1 | $51.4M | Buy |
|
|||||
|
2024
Q4 | $44.5M | Sell |
|
|||||
|
2024
Q3 | $58.8M | Buy |
|
|||||
|
2024
Q2 | $69.7M | Sell |
|
|||||
|
2024
Q1 | $64M | Sell |
|
|||||
|
2023
Q4 | $58.8M | Sell |
|
|||||
|
2023
Q3 | $55.5M | Sell |
|
|||||
|
2023
Q2 | $50.4M | Sell |
|
|||||
|
2023
Q1 | $58.9M | Sell |
|
|||||
|
2022
Q4 | $52.7M | Sell |
|
|||||
|
2022
Q3 | $50.6M | Sell |
|
|||||
|
2022
Q2 | $52.4M | Sell |
|
|||||
|
2022
Q1 | $64M | Sell |
|
|||||
|
2021
Q4 | $60.3M | Sell |
|
|||||
|
2021
Q3 | $58.7M | Sell |
|
|||||
|
2021
Q2 | $55.5M | Sell |
|
|||||
|
2021
Q1 | $47.5M | Sell |
|
|||||
|
2020
Q4 | $51.1M | Sell |
|
|||||
|
2020
Q3 | $62M | Sell |
|
|||||
|
2020
Q2 | $70.4M | Sell |
|
|||||
|
2020
Q1 | $58.5M | Sell |
|
|||||
|
2019
Q4 | $53.2M | Sell |
|
|||||
|
2019
Q3 | $43M | Sell |
|
|||||
|
2019
Q2 | $50.7M | Sell |
|
|||||
|
2019
Q1 | $70.3M | Sell |
|
|||||
|
2018
Q4 | $66.3M | Sell |
|
|||||
|
2018
Q3 | $76.8M | Sell |
|
|||||
|
2018
Q2 | $73.4M | Sell |
|
|||||
|
2018
Q1 | $83M | Sell |
|
|||||
|
2017
Q4 | $92M | Sell |
|
|||||
|
2017
Q3 | $118M | Sell |
|
|||||
|
2017
Q2 | $131M | Sell |
|
|||||
|
2017
Q1 | $108M | Sell |
|
|||||
|
2016
Q4 | $105M | Sell |
|
|||||
|
2016
Q3 | $123M | Sell |
|
|||||
|
2016
Q2 | $108M | Buy |
|
|||||
|
2016
Q1 | $111M | Buy |
|
|||||
|
2015
Q4 | $165M | Sell |
|
|||||
|
2015
Q3 | $148M | Sell |
|
|||||
|
2015
Q2 | $190M | Sell |
|
|||||
|
2015
Q1 | $187M | Sell |
|
|||||
|
2014
Q4 | $185M | Sell |
|
|||||
|
2014
Q3 | $166M | Sell |
|
|||||
|
2014
Q2 | $146M | Sell |
|
|||||
|
2014
Q1 | $164M | Sell |
|
|||||
|
2013
Q4 | $155M | Sell |
|
|||||
|
2013
Q3 | $190M | Sell |
|
|||||
|
2013
Q2 | $140M | Buy |
|